Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
https://www.gocct.com/2022/02/17/concurrent-technologies-cenkos-securities-growth-innovation-forum/
Contains some proposals for what transformations will be planned as new board take over the business. Be interesting to see what has been achieved when we get interims. As he says, there is huge potential for the company to grow.
interim results for the six months to 30 June 2022 on Monday, 26 September 2022.
Another 380k at 88p. Lets hope they go to sticky hands.
So Premier Miton, now increased from 14% to 15%, on 17th then the 15% to 16% on the 22nd.
More confirmation that this is a strong buy.
If you add in Liontrust & BNY, then that is 33% shares held between 3 II's.
(BNY are listed as Diverse Income Trust on the website.)
Interims should be around week 1 of September, with Notice of results 1 week prior. Looking forward to them.
Last research I could find, said EPS might be affected by component shortages for this 6 months, but I guess it is the forward looking side we are interested in.
Extra 430k shares tonight, still buying? Obviously for this type of volume there is a seller too, but nice to see institutional interest.
There you go!
I think that is the Bank of New york. Now up from 5% to 6%. Interestingly they are not listed on the company website as a significant holder, not sure why.
This is setting up to be fantastic share IMO. Under the radar, no one interested, not many free shares, new BOD, plenty of funds, mature company, products in demand, selling to recession proof sectors. Cant wait!
Yesterday (18/08/2022) was interesting. Late trades came in for over 1M shares. 1.075M to be precise, all at a price of 87p.
That is 1.36% of the company on the book. Perhaps in time, something will be revealed? TR1 either way maybe?
Highest volume since 16th March 2021.
Doubt it would be the board, as probably closed period, although im hopeful of director buying after interims.
Look at that cup and saucer, even looks good on this web site (unusual). I suspect the interim's in early September will be the catalyst. I'm still here...
Not easy to dig up much research on this company. My day job is embedded software, and from what I can see this is a pretty special company. For example, releasing boards with new Intel processors on, on the day that Intel launch the processor, tells you that they are high up the food chain. To be getting early samples to work on etc. (and likely a supply agreement). These boards are pretty awesome and suited to most demanding applications as they say on the website.
I expect some re rating in the share price due to earnings increases / new contracts. Longer term though im wondering if there is much high growth in this company as it has been around for 20 years. Probably more of a value play this one?
Also not on any ones radar, (yet). We need to see more spending on defense, it must be coming.
Investors chronicle has some broker ratings tucked away on their web site, and 2 of 2 brokers say 'out perform'. Target price circa £1.20. I have shares for trading and long term investment here.
Thanks Darton - fingers crossed you're right!
Spoontrader, I bought in here after analyzing the chart. I believe 95p would be the start of the move. Id be looking for a serious rise once £1 breaks.
Good move today and getting close to my .95 target. As is always the way, I’m now feeling greedy and think I’ll stick in there until we go through £1. No discipline at all!!!
Good news this morning re new supply agreement. Particularly pleased to see a nod in the announcement to
Concurrent being able to manage supply chain issues. Obviously the multi-year nature of the contract and it being paid for in dollars (given the current state of the £) are also big pluses. Extract from the RNS below:
“Concurrent Technologies… has entered into a supply agreement with a Fortune 500 global medical technology company, and has received an initial USD$2.2 million order for first year product shipments. Initial shipments have already commenced for qualification purposes with volume shipments scheduled to start at the end of 2022. The customer is then expected to place similar size orders on an annual basis for several years to come.
The customer's needs were multi-faceted and challenging. Concurrent Technologies developed a product that maintained backwards compatibility with the external interfaces of the prior product; demonstrated the ability to manage and overcome issues that would prevent multi-year production without changes; and met all the customer's quality and supply chain requirements.”
@huwie - it’s classic concurrent tbh. The board are always upfront around challenges. For me I think it’s a good thing and very rarely do they seem to miss guidance. The market doesn’t seem to agree in the short term but as I’m holding longer term I’m fine with the approach. Topped up at 76.6p - have a fair few so will likely sell some once the sell price goes north of 95p
In my opinion the CEO should not have said, “ Despite growing demand for our products and an increased order book, we do expect short-term supply challenges will result in delivery of it being more protracted than is normal for the Group”.
That’s what he thinks but should have remained Shtum.
Always the way with Concurrent. Solid results but the share price dips. Very tempted to pick up some more but expect the spread is horrendous (as always)…
One word really. Absurd. We're not fashion retail or some loss making new tech. Cutting edge defence technology with a strong future and a decent dividend. Might get taken over I suppose, only small change for the big guys, which would disappointing.
Keep calm and carry on RNS. No sinking ship here.
Results and Zoom meeting tomorrow
Presentation and update on Investor Meet Company on Monday 16th.
Sadly with everyone bulking up in defence, I want be surprised for a third or is it fourth consecutive year update of record orders exceeding expectations.
There have been a umber of board changes. I think many don't realise this company was founded in 1982 I think. Definitely eighties. Unsurprisingly there have been a few retirements and the death of one of the founders. So yes there has been a transitional phase. Illness in both company and auditors have delayed results. Apparently they may even have to appoint another auditor. However despite set backs, if they are seen as such, trading is expected to be slightly ahead of expectations. There are a lot worse investments out there and I'm getting 3.5% div on my original investment.
Difficult to tell imo. Last CFO resigned. Second such. But new one appointed straight away. Has there been trouble a't mill?
At least the spread is more sensible than normal for some reason. All this trouble its hard to tell what to make of anything market wise
Typically idiotic reaction from the market, with another quality replacement CFO and exec director from QQ.as the good Doctor builds a sold and exciting team to take the Tardis into a new phase.
Thanks for that Wealth. I think that is a pretty frank and honest appraisal by our new CEO. I know there have been some holders have been here for a very long time. It was one now defunct Aim Investment Trusts top holdings way back and also Lord Lee has been a long term holder with connections on the UK defence Committee. I think most of us have been aware that it has been a difficult year for techs aside from component shortages. It sounds like the good doctor has got this potential thoroughbred by the scruff of the neck and going to unleash its pent up potential. Very exciting. Not something I've been able to say about CNC before and you can tell the CEO is too
Above should read 3 hours 16 mins 40secs